Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Operations

Verovaccines gets larger research facility as company goes standalone

German start-up Verovaccines will further develop its pipeline at a new R&D facility in Halle.

Operations R&D

DSM to stimulate above-market animal nutrition growth with gut health, digitization

Royal DSM aims to continue outperforming the global animal nutrition market through gut health innovation, geographic expansion and M&A in the premix area.

Feed & Additives Operations

BioMar expands R&D focus in hatchery feed sector

Denmark's leading aquaculture feed company BioMar has improved its domestic hatchery research capabilities.

Denmark Operations

KCALSI rebrand to underline One Health focus

The Kansas City Area Life Sciences Institute (KCALSI) is to be renamed BioNexus KC – a rebranding that highlights the organization's work in both animal and human health.

United States Operations

Boehringer to make record €200m investment in France's vaccine valley

Boehringer Ingelheim has continued to develop its network of vaccine capabilities by spending over €200 million ($235 million) to establish a new vaccine production center in France.

Boehringer Ingelheim Animal Health Vaccines

Phibro to establish first vaccine manufacturing plant in Europe

Phibro Animal Health plans to establish a new vaccine production facility in Sligo, Ireland.

Phibro Animal Health Ireland

Ceva moves further into Nigerian poultry market with Olam agreement

Ceva Santé Animale has strengthened its presence in the sub-Saharan Africa market by securing Olam Hatcheries as a partner.

Ceva Sante Animale R&D

Zomedica announces interim closing, extension of private offering

US animal health firm Zomedica Pharmaceuticals has effected an interim closing and announced an extension of its private offering.

Investments Operations

Zoetis sets up virtual hub to counter outbreaks of infectious diseases

Zoetis aims to improve reactions to new outbreaks through the establishment of the Center for Transboundary and Emerging Diseases.

Zoetis Operations

Brazilian mastitis diagnostics firm reaches out to distributors

Brazil's NGS Soluções Genômicas wants to take its mastitis diagnostics to international markets through distribution partners.

Diagnostics Mastitis

Nutrition and genetics support Benchmark H1 growth

UK aquaculture health company Benchmark posted a sales increase of 9% for the first half of 2018.

Financial Results Operations

Heska expects to grow at double-digit annual rate to 2022

US veterinary diagnostics company expects to grow its annual revenues by around 13.5% per year through 2022.

Heska Diagnostics